Market Size (2019)
2019
$726.09M
Vertical: HealthcareBase Year: 202212 Sections
Market Size (2019)
2019
$726.09M
Projected (2030)
2030
$1.47B
CAGR (2019–2030)
6.6%
6.6%Key Players
104+
This report covers Cardiopulmonary Exercise Testing Market with forecasts from 2019 to 2030. 104 key companies are profiled.
The Cardiopulmonary Exercise Testing Market market is projected to grow at a CAGR of 6.6% from 2019 to 2030.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAnalysis of Cardiopulmonary Exercise Testing Market from 2019 to 2030. Covers North America, Europe, Asia Pacific, Rest of the World.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2022
Historical Period
2019 – 2022
Forecast Period
2022 – 2030
Primary Interviews
150+
Historical data (2019–2022) and forecast period (2022–2030)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket estimates by geography (2030)
InsightNorth America leads with $613.20M by 2030, while Asia Pacific is projected to grow fastest at a 8.6% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2019 | 2022 | 2030 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $263.71M | $399.77M | $613.20M | 8.0% | 42% |
| Europe | $250.43M | $316.99M | $416.94M | 4.7% | 28% |
| Asia Pacific | $121.04M | $190.08M | $299.16M | 8.6% | 20% |
| Rest of the World | $90.92M | $112.81M | $142.96M | 4.2% | 10% |
| Total | $726.10M | $1.02B | $1.47B | 6.6% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.47B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| CPET Metabolic Carts | $1.04B | 6.6% | 85% |
| Software | $431.39M | 6.6% | 89% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Cardiopulmonary Exercise Testing Market covering market dynamics, competitive landscape, and strategic outlook.
The Cardiopulmonary Exercise Testing Market market is projected to reach $1.47B by 2030, growing at 6.6% CAGR. The CPET Metabolic Carts segment holds the largest share.
The Cardiopulmonary Exercise Testing Market market encompasses 4 key regions and 2 market segments, with the study period spanning 2019 to 2030. The market demonstrates a 6.6% compound annual growth rate, reflecting strong underlying demand fundamentals.
Among the identified segments, CPET Metabolic Carts leads with $1.04B by 2030, followed by Software at $431.39M. These segments collectively account for the largest share of total market revenue.
This report profiles 104 key companies operating in the Cardiopulmonary Exercise Testing Market market, covering market positioning, product portfolios, and recent developments.
Leading players include Schiller AG, COSMED Srl , MGC Diagnostics Corporation, Oxigraf, Inc , Vyaire Medical, Inc. , and 99 others.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 104 companies operating in the Cardiopulmonary Exercise Testing Market market, including revenue, employee count, and market positioning where available.
Showing 104 of 104 companies
Geratherm Medical AG
Company Headquarters: Bad Kissingen, Germany Founded: 1900 Workforce: ~ 226 Company Working: Geratherm Medical AG is a medical device company that is engaged in the development of various medical devices such as pulmonary function testing devices, cardiopulmonary exercise devices, spirometers, body plethysmographs, CO diffusion, CPET, and medical devices. The company operates its business through the segment including healthcare diagnostic, respiratory, cardio/stroke, and medical warming systems. The company has extensive distribution network in North America, Europe, Asia-Pacific, and Rest of the World.
MEDEV Medical Devices Corporation
Company Headquarters: Philippines, Saudi Arabia Founded: 1999 Workforce: ~50 Company Working: MEDEV Medical Devices Corporation is a well-established manufacturer and distributor of medical equipment in the field of critical care, cardiology, radiology, obstetrics and gynecology, peripheral vascular medicine, rheumatology, and others. The company specialized in ultrasound equipment, medical imaging, lasers, dermatological and aesthetic, ECG systems (Resting, Holter, Stress), EEG systems, X-ray systems, mammography, mobile C-arm, transcranial magnetic stimulation (TMS), PFT, CPET, spirometry, and critical care equipment. The company distributes its product in Saudi Arabia.
CORTEX Biophysik GmbH
Company Headquarters: Leipzig, Germany Founded: 1991 Workforce: ~50 Company Working: CORTEX Biophysik GmbH is a fast-growing company that is engaged in the development and manufacturing of medical, fitness, and sports-related products. The company provides products under the product lines METAMAX and METALYZER, the company majorly manufacture mobile and portable cardiopulmonary diagnostic to a high-quality standard. CORTEX all products are CE certified and maintain European standards for quality and safety. The company distributes its products in North America, Europe, Asia-Pacific, and the Rest of the World.
Schiller AG
Company Headquarters: Baar, Switzerland Founded: 1974 Workforce: ~ 1,200 Company Working: Schiller AG (Schiller) is a manufacturer and supplier of cardiopulmonary diagnostics, defibrillation, and patient monitoring devices as well as a software solution. It offers electrocardiography, emergency care and resuscitation, pulmonary function testing, blood pressure, diagnostic station, radiology and interventional cardiology, patient monitoring, critical care, medical IT, robotics, and consumables. It also offers ECG simulation-based e-training services. Moreover, the company distributes products directly and through a network of distributors across the world. Furthermore, the company has its facilities in France, Switzerland, Germany, India, China, and Austria.
MGC Diagnostics Corporation
Company Headquarters: Minnesota, US Founded: 1986 Workforce: 215 Company Working: MGC Diagnostics Corporation creates, produces, and markets non-invasive diagnostic tools for the detection, management, and treatment of cardiorespiratory disease. It provides cardiovascular exercise systems, pulmonary function testing equipment, flow sensors, gas analyzers, spirometers, and related consumables. The company's products have applications in figuring out the right nutritional support needs, evaluating the effectiveness of prescription medications, and using diagnostics to look for early indications of cardiac and pulmonary failure. Through a direct sales force and distributors, it offers its products under the MGC diagnostics and Medisoft brand names to hospitals, university-based medical centers, organizations, clinics, doctor's offices, pharmaceutical firms, medical device producers, and clinical research organizations. Additionally, the business works as a division of CAIRE, Inc. (US). Furthermore, the company has operations in the US, Belgium, France, Australia, and Germany.
COSMED Srl
Company Headquarters: Rome, Italy Founded: 1980 Workforce: ~ 200 Company Working: COSMED srl develops, manufactures, and sells diagnostic medical equipment globally. It offers diagnostic equipment for the metabolism, lungs, and body composition. The company's products include spirometers, Pulmonary Function Test (PFT), Cardiopulmonary Exercise Test (CPET), and indirect calorimetry diagnostic equipment. In addition, COSMED products are designed for either professional or medical use in a variety of settings, including hospitals, clinics, primary care, universities, and education in human physiology, clinical nutrition, commercial weight management, human performance centers, sports institutions, and the health club industry. Moreover, the company has a distributor network that spans more than 80 nations. Furthermore, the company has direct operations in the US, Australia, Switzerland, France, Germany, Netherlands, Denmark, Hong Kong, and the UK.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Cardiopulmonary Exercise Testing Market